The share of production done with external manufacturing partners has doubled in the past 10 years, driven by cost and efficiency constraints coupled with the need to efficiently supply a diverse global patient population. While more and more production is strategically outsourced, the communication and coordination infrastructure to manage these processes hasn't kept pace. A recent study by NC State University found that almost 75% of external manufacturing relationships primarily relied on phone, email and spreadsheets to manage weekly production status and monitor monthly performance.
External supply leaders have historically faced several challenges in tackling this growing issue. Paramount among these questions are: "What tangible benefits can we gain by investing in our external manufacturing processes?" and "How can we practically deploy a harmonized, standard approach across our globally dispersed and highly diverse external manufacturing partner ecosystem?"
To answer the first question, studies by NC State University and other analysts highlight several areas for performance improvement across external pharmaceutical manufacturing through the use of highly connected network platforms, electronic data exchange and collaborative workspaces. These include:
To answer the second question requires a new way of thinking about your external manufacturing ecosystem not as a set of point-to-point supply relationships but instead as a highly connected global network. The tools to manage such a global network and create a supply chain control tower are now available.
TraceLink's high performance network platform and integrated suite of supply management applications helps you ensure the same level of visibility, control and performance across external manufacturing operations that you have over your internal production processes.